Gantt, Soren <br/><br/>
Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.  [electronic resource] 

 -  Journal of medical virology  Jun 2016 
 - 1051-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-9071 
<br/><br/><label>Standard No.: </label>10.1002/jmv.24420  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cohort Studies<br/>Cytomegalovirus--genetics<br/>Cytomegalovirus Infections--congenital<br/>DNA, Viral--blood<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--therapeutic use<br/>Humans<br/>Infant, Newborn<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Mothers<br/>Nelfinavir--adverse effects<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Prevalence<br/>Risk Factors<br/>Young Adult